[Desmopressin: the treatment of primary nocturnal enuresis].
Copyright policy )[Desmopressin: the treatment of primary nocturnal enuresis].
The efficacy of desmopressin, a drug that reduces nocturnal urine volume with no side effects, was evaluated in a group of 21 patients.20 boys and 1 girl with primary nocturnal enuresis were treated with intranasal desmopressin (DDAVP) for a period of 12 weeks.An improvement in 80.95% was achieved. Following treatment enuresis recurred, but to a lesser degree than before therapy.DDAVP is useful in the treatment of primary nocturnal enuresis whose etiology is not organic or functional.
Male, Time Factors, Adolescent, Enuresis, Recurrence, Chronic Disease, Drug Evaluation, Humans, Deamino Arginine Vasopressin, Female, Child
Male, Time Factors, Adolescent, Enuresis, Recurrence, Chronic Disease, Drug Evaluation, Humans, Deamino Arginine Vasopressin, Female, Child
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!